The purpose of this study is to determine whether a medication called Vyvanse®
(lisdexamfetamine; LDX) has an impact on cognitive functioning, specifically measures of
sustained attention, verbal encoding and recall and working memory, in menopausal aged women.
LDX is a medication used to treat attention deficit hyperactivity disorder (ADHD). The
cognitive difficulties that menopausal women report experiencing are typical of adults who
are diagnosed with ADHD. The investigators will assess whether or not LDX is effective in
alleviating those cognitive disruptions when compared to a placebo.